US 11,890,605 B2
Composite metal organic framework materials, processes for their manufacture and uses thereof
David Fairen-Jimenez, Cambridge (GB); Tian Tian, Cambridge (GB); Joshua Mehta, Cambridge (GB); Andrew Wheatley, Cambridge (GB); and Bethany Connolly, Cambridge (GB)
Assigned to Cambridge Enterprise Limitd, Cambridge (GB)
Appl. No. 16/608,724
Filed by Cambridge Enterprise Limited, Cambridge (GB)
PCT Filed Apr. 27, 2018, PCT No. PCT/EP2018/060986
§ 371(c)(1), (2) Date Oct. 25, 2019,
PCT Pub. No. WO2018/197715, PCT Pub. Date Nov. 1, 2018.
Claims priority of application No. 1706805 (GB), filed on Apr. 28, 2017.
Prior Publication US 2020/0179916 A1, Jun. 11, 2020
Int. Cl. B01J 35/04 (2006.01); B01J 35/00 (2006.01); B01J 20/22 (2006.01); B01J 21/06 (2006.01); B01J 23/06 (2006.01); B01J 23/14 (2006.01); B01J 23/44 (2006.01); B01J 23/52 (2006.01); B01J 35/02 (2006.01); B01J 35/10 (2006.01); B01J 37/00 (2006.01); C02F 1/30 (2023.01); C02F 1/72 (2023.01); C02F 101/30 (2006.01)
CPC B01J 35/004 (2013.01) [B01J 20/226 (2013.01); B01J 21/063 (2013.01); B01J 23/06 (2013.01); B01J 23/14 (2013.01); B01J 23/44 (2013.01); B01J 23/52 (2013.01); B01J 35/023 (2013.01); B01J 35/1014 (2013.01); B01J 35/1023 (2013.01); B01J 37/0009 (2013.01); C02F 1/30 (2013.01); C02F 1/722 (2013.01); C02F 2101/308 (2013.01); C02F 2305/08 (2013.01); C02F 2305/10 (2013.01)] 8 Claims
OG exemplary drawing
 
1. A process for manufacturing a monolithic metal-organic framework (MOF) composite body, the process comprising the steps:
providing MOF precursors;
providing nanoparticles having an average particle size corresponding to an average particle diameter in the range 3-200 nm;
providing at least one solvent;
allowing the reaction of the MOF precursors in the solvent in the presence of the nanoparticles;
carrying out a drying stage with a maximum temperature in the drying stage of not more than 80° C. to form a monolithic MOF composite body having a smallest dimension of at least 1 mm, the MOF composite body comprising MOF crystallites adhered to each other via a binder comprising MOF, and incorporating at least 0.15 vol % and at most 1 vol % of the nanoparticles encapsulated in MOF.